BD Biosciences’ Post

Thermo Fisher Scientific has a blog! And our "Behind the Bench Staff" wrote a post about tackling the Challenges in CAR T Cell Therapy Manufacturing! Click here for the post👉 https://lnkd.in/gjcyFb-n What I like most about the post is a short 100sec clip that shows our instruments designed for cell therapy manufacturing working together. You can also watch it directly here: https://lnkd.in/ezgYysCX

🔬 New Case Study: Rapid Road to Qualification: A Breakthrough Story Against Time In our latest case study, learn how the dedication and scientific expertise of Joan Hilly Foster, MaxCyte’s Principal Field Application Scientist, helped a stealth mode cell therapy company overcome a critical challenge, and successfully reach their next inflection point. This inspiring success story underscores our unwavering commitment to customer success and driving progress toward clinical milestones. Read the full case study. https://bit.ly/3Ua44jA

On-Demand Webinar: Reduce Waste, Boost Performance, and Future-Proof your Bioprocess Supply Chain! Discover how Nexcel® BIO1250, a film technology by Sealed Air, can revolutionize your bioprocessing operations. Our on-demand webinar explores how to: Extend container lifespans and reduce waste Improve workflow efficiency and cost-effectiveness Ensure compliance with critical industry regulations Watch now and unlock the potential of Nexcel® BIO1250 for your cell culture or cell therapy process: https://lnkd.in/efUjFvGr #bioprocessing #efficiency #wastereduction #cellculture #celltherapy #nexcel #webinar #ondemandwebinar

Exciting insights from our recent trip to the 3rd Annual Process Development for Cell Therapies Summit in Boston! Operations Manager Marnie Wilson and Process Development Lead Janna Kozuska came away with three key takeaways: 1) Collaboration between research teams and process development teams is crucial for bridging gaps and enhancing project outcomes. 2) Effective communication between the client and CDMO is essential for project success. 3) The summit highlighted that observing inherent particles during visual inspections in cell therapy is a common occurrence. Bonus takeaway: Trader Joe's Rules!!! #CDMO #celltherapies #processdevelopment #techtransfer #traderjoes

🔍 Have you ever wondered how raw materials are evaluated for cell therapy manufacturing? Our handbook provides a comprehensive framework that categorizes raw materials based on their risk levels. 📚 #CellTherapy

Looking forward to this Webinar hosted by BioSurfaces, LLC Disruptive technology can be as simple as utilizing innovations from adjacent industries to solve cell therapy challenges. When thinking 'outside of the box', check out what's in the box next-door :)

Centrifuges play a crucial role in cell therapy manufacturing processes. Centrifuges are utilized at different stages of cell therapy manufacturing for various purposes, including cell separation, cell washing, and cell concentration. Discover insights into the specific applications of centrifuges in cell therapy manufacturing and access a wider array of case studies and white papers by exploring further here: https://hubs.ly/Q02r-2PK0 #CARRBiosystems #Centrifugation #SingleUseCentrifuge #cellharvesting #singleuse #cellandgenetherapy #lowshear #celltherapy #bioprocessing #lifesciences

Today, we are excited that GC Therapeutics emerged from stealth to announce its Series A raise. At Pear VC, part of our thesis within life sciences revolves around transformative technologies enabling the next generation of emerging modalities. One such modality, induced pluripotent stem cell (iPSC)-derived therapies, holds great promise to address a broad range of diseases. However, challenges in manufacturing, namely, complex and lengthy differentiation protocols, poor yields, and batch-to-batch variability, have severely limited this potential. Long design-build-test-learn cycles further hinder the rapid, scalable engineering and optimization of these products. With this mindset, when we met Parastoo Khoshakhlagh, Ph.D. and Alex Ng, Ph.D., we were impressed with how they and their colleagues had leveraged the TFome™ platform, GCTx’s iPSC cellular programming technology developed in the lab of Prof. George Church at Harvard Medical School and the Wyss Institute at Harvard University, to quickly accelerate development of best-in-class iPSC-derived cell therapies. The team quickly demonstrated the ability to make multiple high value cell types of interest from iPSCs via a single step process, offering several-fold improvements in time and cost without compromising potency or quality. The internal therapeutic programs focus on areas of severe unmet need across gastrointestinal, neurological, and immunological diseases, and beyond the core pipeline, the platform offers multiple opportunities for partnering. For these reasons, we were thrilled to welcome GCTx to the Pear portfolio, and we look forward to working with Parastoo, Alex, Cory Smith, and George, as well as our fellow investors at Cormorant Asset Management, LP, Mubadala Capital, Andreessen Horowitz, Medical Excellence Capital, LLC, among others, to support the company in its mission.

If you haven't seen Slingshot Biosciences's YouTube channel, come and explore our channel at https://lnkd.in/g3cwsUYV! Delve into cell control innovation, gain expert analyses, in-depth knowledge, and the latest updates! Join our community and subscribe to stay informed. #CellControl #CellBiology #FlowCytometry #SubscribeNow

Did you know that the Gibco™ CTS™ Immune Cell Serum Replacement is specifically designed for use in cell therapy manufacturing? From using the right raw materials and closed, automated systems to supply chain logistics, learn everything you need to know about Cell Therapy manufacturing in our handbook.